Phosphorylation of AIB1 at mitosis is regulated by CDK1/CYCLIN B

Macarena Ferrero1, Juan Ferragud, Leonardo Orlando

  • 1Laboratory of Cellular and Molecular Biology, Centro de Investigación Príncipe Felipe, Valencia, Spain.

Plos One
|December 14, 2011
PubMed
Abstract

Insights

The oncogene AIB1 is phosphorylated during mitosis by Cdk1/cyclin B, causing it to move away from chromatin. This phosphorylation by Cdk1/cyclin B regulates AIB1

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Gene Regulation

Background:

  • The AIB1 oncogene is a known coactivator of E2F1 during the early cell cycle.
  • Its precise function during mitosis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role and regulation of AIB1 during mitosis.
  • To elucidate the post-translational modifications and subcellular localization of AIB1 in mitotic cells.

Main Methods:

  • Isolation of mitotic cells via nocodazole treatment and shake-off.
  • In vitro kinase assays and phosphatase sensitivity tests.
  • Western blotting, flow cytometry, luciferase reporter assays, and fluorescence microscopy.

Main Results:

  • AIB1 undergoes phosphorylation on Ser728 and Ser867 by Cdk1/cyclin B at mitosis onset.
  • Phosphorylation leads to AIB1 exclusion from condensed chromatin and peripheral localization.
  • This mitotic phosphorylation does not affect AIB1's transcriptional activity or lead to degradation.
  • Dephosphorylation at mitosis exit is mediated by PP1.

Conclusions:

  • A novel mechanism regulates AIB1 during mitosis through Cdk1-mediated phosphorylation.
  • Phosphorylation causes AIB1's redistribution from chromatin to the cell periphery.
  • This spatial regulation likely controls AIB1's transcriptional activity during mitosis.

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...